Abstract:The Astrophysical Journal for October, 1914, contained an important paper by MM. Bourget, Fabry, and Buisson of Marseille, summarizing the results of their application to the Orion nebula of the photographic interferometric methods of M. Fabry. They found var'ations 'n the radial velocity from one point to another within the nebula, differences as large as 10 km. per second at points quite close to each other being indicated by local deformations of the interference rings. They also detected graat collective movements, the northeastern region receding, and the southwestern region approaching, relatively to the mean velocity at the trapezium, with velocities of about 5 km. per second. It seemed of interest to repeat these determinations independently by the standard spectrographic method, and toward the close of the winter observations were begun at Yerkes Observatory with the Bruce spectrograph, arranged with a dispersion of one prism. The radial velocity was inferred from the displacements of the hydrogen lines 0 and 7 and the lines of nebulium at X 5007 and 4959. At the position of the western star of the trapezium, No. 619 in Bond's catalogue of stars in the nebula, the radial velocity of the nebula was found from measures .of eight plates (taken occasionally during the past eleven years) to be + 15.6 * 0.5 km. per second (recession). This is the mean of independent measures of each plate by the writer and Mr. C. A. Maney, and it agrees almost exactly with the value of + 15.8 km. found by the observers at Marseille for the region of the trapezium. For several other positions around the trapezium, and not over 2' from it; we obtained values ranging from +6 to +17 km. The probable error for the velocity at one point, from the mean of measures by the two observers of a single plate, should be about == 1.5 km., so that the reality of the difference may be regarded as fully confirmed. Exposures of from two to three hours were required at some of the positions, so that the accumulation of plates was slow, and additional observations will be required when the 'open season' for Orion returns. We must accordingly alter our conceptions of the nebula as an enormous mass of quiescent gas, and regard it as seething with local whirlpools besides perhaps having a considerable motion of rotation as a whole. 416

CAR T-cell therapy in cancer: Integrating nursing perspectives for enhanced patient care

HoneyLedgerBFT : Enabling Byzantine Fault Tolerance for the Hyperledger platform

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments

Educating Multidisciplinary Care Teams, Patients, and Caregivers on CAR T-Cell Therapy

CAR‐T Therapy in Clinical Practice: Technical Advances and Current Challenges

Harnessing the potential of CAR-T cell therapy: progress, challenges, and future directions in hematological and solid tumor treatments

CAR-T cell therapy: a game-changer in cancer treatment and beyond

Radial Velocities Within the Great Nebula of Orion.

OPPORTUNITIES AND CHALLENGES FOR CAR T-CELL THERAPY IN CANCER

Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies

CAR T-Cell Therapy: The Next Frontier for Cancer Immunotherapy

CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities

From bench to bedside: the history and progress of CAR T cell therapy

Strategies for Developing Oral Vaccines for Human Papillomavirus (HPV) Induced Cancer using Nanoparticle mediated Delivery System.

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions

Methodology, Applications and Advancements of Car-T Cell Therapy in Malignancies

Potential of chimeric antigen receptor (CAR)‐redirected immune cells in breast cancer therapies: Recent advances

Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies

Advances and challenges in chimeric antigen receptor‐natural killer cell immunotherapy for cancer